TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Poor glycemic control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in general anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improved mindfulness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in SAQ scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-month RFS probability
Endpoint domain: Mortality/survival
Primary endpoint: Pain scores at rest or on coughing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of direction (COD) performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in fetal heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fewer episiotomies on fetal indication
Endpoint domain: Adverse events/effects
Primary endpoint: binocular uncorrected visual performance at intermediate and near distances
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved knowledge about evidence-based practices (EBPs)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Strong intentions to deliver EBP core components
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Identification of cases and provision of appropriate treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cardiac efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: compound muscle action potential amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in avoidance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in distress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Leader self-efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of no-shows
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of patients with endoscopic recurrence at 26 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative rate of clinical recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participants receiving no medication treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Last visit medication prescriptions for antipsychotic medication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anticonvulsant mood-stabilizing medication prescriptions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: global health-related quality of life (QoL) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Intrasurgical hemorrhaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Postoperative pain (VAS scoring)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum TBIL levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Gastric thick fluid volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: 24-hour urine osmolality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage accuracy in CXR interpretation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean weighted NLDO score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Axial Length (AL) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spherical Equivalent Refraction (SER) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of Staphylococcus aureus colonization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Improvement in Eczema Area And Severity Index scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inspiratory positive airway pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: TCM symptom pattern score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Menstrual cycle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correction of kyphosis deformity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cobb angle of the postoperative coronal plane
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Volume of RBC transfusion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: turnover intention
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: anteroposterior stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corrected efficacy at D28
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of BAT for metronidazole
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sensitivity of BAT for ornidazole
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Positive predictive value (PPV) of STs for metronidazole/ornidazole
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: First-pass rate for left atrial access
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dermal blood flow responses to capsaicin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in triptan use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time to failure after SLT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Flap failure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Flap-related complications rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: reaction time of incongruent trials in the SCWT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: commission errors in the Go/No‐Go task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: interference score in SCWT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean distances achieved during the 6MWT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for portable oxygen device
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: postoperative visual outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spiculated mass prevalence after DBT screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Calcifications prevalence after DM screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Stress levels measured by Depression, Anxiety and Stress Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Stress reduction measured by Lipp’s Stress Symptoms Inventory for Adults
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of patients in exhaustion stage
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Hospitalization due to SARS-CoV-2 infection
Endpoint domain: Mortality/survival
Primary endpoint: Symptom duration after SARS-CoV-2 infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive PCR test results for SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Sustained remission at 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequent relapses
Endpoint domain: Adverse events/effects
Primary endpoint: accuracy of periodontal diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-confidence scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: change in left ventricular ejection fraction (LVEF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: EuroQol-5D-5L index value
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Total hair density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative hair diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of poor prognosis
Endpoint domain: Adverse events/effects
Primary endpoint: Isometric and dynamic performance during chin-up tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion rate of the course
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: mean total SPADI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: K-SES scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Annual earnings
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Disability benefits usage
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: final blood glucose value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: variation of blood glucose reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Need for surfactant
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of RDS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Social adaptability
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Insertion to delivery time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ODI walking item
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: task specific training
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: participation in modified sport and fitness activities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: monitoring on long-term pathways for children with Gross Motor Function Classification System level III
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transprosthetic gradients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aortic valve areas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration needed to achieve culture negativity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: K-D test performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: False-positive rate of K-D test
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical scarring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Blood EOS count variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: risk of total stroke
Endpoint domain: Mortality/survival
Primary endpoint: risk of intracerebral hemorrhage
Endpoint domain: Mortality/survival
Primary endpoint: Basal IL-6 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: VFT rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients receiving allogeneic RBCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Rate of severe postoperative complications (Clavien-Dindo grade IIIa and higher)
Endpoint domain: Adverse events/effects
Primary endpoint: Breast thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MGD (Mean Glandular Dose)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SER progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of worsening heart failure or cardiovascular death
Endpoint domain: Mortality/survival
Primary endpoint: Naloxone dispensation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: heart failure self-care improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FBG change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: recurrence rate after six months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Rate of thiopurine-induced leucopenia
Endpoint domain: Adverse events/effects
Primary endpoint: Malalignment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative ankle function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: motor coordination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: MRI ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of new-onset adrenal insufficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in SALT score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SALT30/SALT50/SALT75 improvement rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of major breast-related complications
Endpoint domain: Adverse events/effects
Primary endpoint: Mean state anxiety levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pregnancy-related anxiety scores (PRAQ-R)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Osteoprotegerin and sclerostin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time required to establish a passage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiation exposure (DAP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mortality benefit from screening
Endpoint domain: Mortality/survival
Primary endpoint: Estimated Fetal Weight (EFW)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary endpoint on TOC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Significant growth of E.coli on TOC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Seroconversion defined as ≥3-fold increase in IgA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Abdominal aortic calcification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean post-test scores for ALC
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mean post-test scores for PLC
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: canal transportation (apical 3 mm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: file distortion
Endpoint domain: Adverse events/effects
Primary endpoint: Postprandial area under the curve (AUC) for fullness and satiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: decreases in stress and anxiety
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement between Checkup and reference tests for visual acuity (VA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Usability of Checkup
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Decrease in high-risk patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain scores at rest and during walking 24 hours postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of analgesics after discharge
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Attitudes toward diabetes self-care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived control toward diabetes self-care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Behavioral intentions for diabetes self-care
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Esophageal occlusion success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diameter of the esophagus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predictive accuracy of AI model
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Composite formative test scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: first-primary-outcome event
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Satisfaction degree of nursing care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PrEP adherence at month 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C-index of the radiomics nomogram
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: information literacy self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: %HDD reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total narcotics consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: AUC values of ethinylestradiol and levonorgestrel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of ethinylestradiol and levonorgestrel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC values of furosemide and rosuvastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax in the fed versus fasted condition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tolerability of Trofinetide
Endpoint domain: Adverse events/effects
Primary endpoint: changes in vital signs or laboratory parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composite flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CMA incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Care satisfaction of caregivers
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cognitive effort costs
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mean fT > MIC of 4 mg/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Half life of ceftobiprole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall exposure (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parenting self-efficacy scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Agatston coronary artery calcium score (CACS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in postural control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FABQ-PA mean scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: satisfaction with the clinical learning environment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Development of necrotising enterocolitis (NEC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Age of achievement of full oral feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 4-h TG WCV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 2-h glucose WCV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: adjudicated malignancies
Endpoint domain: Adverse events/effects
Primary endpoint: Contribution to leadership statements
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Contribution to critical treatment decisions
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: occurrence rates of complications
Endpoint domain: Adverse events/effects
Primary endpoint: rate of unexpected hospital return
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: HiSCR rate at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: International Hidradenitis Suppurativa Severity Score (IHS4) at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quit success
Endpoint domain: Mortality/survival
Primary endpoint: acceptance of cravings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes